Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection
Hong Wang,Cuicui Liu,Xiaowei Xie,Mingming Niu,Yingrui Wang,Xuelian Cheng,Biao Zhang,Dong Zhang,Mengyao Liu,Rui Sun,Yezi Ma,Shihui Ma,Huijun Wang,Guoqing Zhu,Yang Lu,Baiming Huang,Pei Su,Xiaoyuan Chen,Jingjing Zhao,Hongtao Wang,Long Shen,Lixia Fu,Qianqian Huang,Yang Yang,He Wang,Chunlong Wu,Weigang Ge,Chen Chen,Qianyu Huo,Qingping Wang,Ying Wang,Li Geng,Yan Xie,Yi Xie,Lijun Liu,Jianwei Qi,Huaiyong Chen,Junping Wu,Erlie Jiang,Wentao Jiang,Ximo Wang,Zhongyang Shen,Tiannan Guo,Jiaxi Zhou,Ping Zhu,Tao Cheng
DOI: https://doi.org/10.1016/j.immuni.2023.05.007
IF: 32.4
2023-05-01
Immunity
Abstract:Although host responses to the ancestral SARS-CoV-2 strain are well described, those to the new Omicron variants are less resolved. We profiled the clinical phenomes, transcriptomes, proteomes, metabolomes, and immune repertoires of >1,000 blood cell or plasma specimens from SARS-CoV-2 Omicron patients. Using in-depth integrated multi-omics, we dissected the host response dynamics during multiple disease phases to reveal the molecular and cellular landscapes in the blood. Specifically, we detected enhanced interferon-mediated antiviral signatures of platelets in Omicron-infected patients, and platelets preferentially formed widespread aggregates with leukocytes to modulate immune cell functions. In addition, patients who were re-tested positive for viral RNA showed marked reductions in B cell receptor clones, antibody generation, and neutralizing capacity against Omicron. Finally, we developed a machine learning model that accurately predicted the probability of re-positivity in Omicron patients. Our study may inspire a paradigm shift in studying systemic diseases and emerging public health concerns.
immunology